GLP-1 receptor agonist impact gutmicrobiota and intestinal immunity to improve hyperglycaemia and dyslipidaemia in rodents

R. Burcelin (1) , J. E. Christensen (1) , J. Charpentier (1) , Aurélie Waget (1) , T. Sulpice (2) , B. Lelouvier (3) , Laurence Guzylack-Piriou (4) , Florent Briand (2)

1 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse
2 Physiogenex
3 Vaiomer
4 ToxAlim - ToxAlim

Domaines: Sciences du Vivant [q-bio]

R. Burcelin, J. E. Christensen, J. Charpentier, Aurélie Waget, T. Sulpice, et al.. GLP-1 receptor agonist impact gutmicrobiota and intestinal immunity to improve hyperglycaemia and dyslipidaemia in rodents. 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), European Association for the Study of Diabetes (EASD). GBR., Sep 2017, Lisbon, Portugal. pp.1. ⟨hal-02733656⟩